MCNULTY KOREA CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,610 KRW | -0.75% |
|
+3.48% | +8.98% |
| 2023 | Mcnulty Korea Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2021 | Mcnulty Korea Co., Ltd. announced that it has received KRW 10 billion in funding | CI |
| Sales 2022 | 70.21B 51.82M 4.14B | Sales 2023 | 78.4B 57.86M 4.62B | Capitalization | 46.42B 34.26M 2.73B |
|---|---|---|---|---|---|
| Net income 2022 | -3.22B -2.37M -190M | Net income 2023 | -3.4B -2.51M -200M | EV / Sales 2022 | 0.99 x |
| Net Debt 2022 | 14.65B 10.81M 863M | Net Debt 2023 | 15.79B 11.65M 930M | EV / Sales 2023 | 0.79 x |
| P/E ratio 2022 |
-16.8
x | P/E ratio 2023 |
-13.6
x | Employees | 105 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.99% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.75% | ||
| 1 week | +3.48% | ||
| Current month | -1.18% | ||
| 1 month | +5.98% | ||
| 3 months | +0.22% | ||
| 6 months | +8.73% | ||
| Current year | +8.98% |
1 week
4 520.00
5 090.00
1 month
4 220.005 090.00
Current year
4 025.005 190.00
1 year
4 000.006 580.00
3 years
4 000.0013 000.00
5 years
2 760.0013 000.00
10 years
2 760.0015 425.00
| Managers | Title | Age | Since |
|---|---|---|---|
Eun-Jung Lee
CEO | Chief Executive Officer | 60 | 18/12/97 |
Seung-Won Kang
BRD | Director/Board Member | 55 | - |
Byung-Min Choi
AUD | Comptroller/Controller/Auditor | 64 | 28/02/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Seon-Tae Jeong
BRD | Director/Board Member | 67 | - |
Eun-Jung Lee
CEO | Chief Executive Officer | 60 | 18/12/97 |
Seung-Won Kang
BRD | Director/Board Member | 55 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/05/24 | 4,610 | -0.75% | 32,264 |
| 02/05/24 | 4,645 | -0.43% | 60,360 |
| 30/04/24 | 4,665 | +1.30% | 89,957 |
| 29/04/24 | 4,605 | +3.37% | 581,074 |
End-of-day quote Korea S.E., May 02, 2024
More quotes
Mcnulty Korea Co., Ltd. is a Korea-based company mainly engaged in the manufacture of coffees. The Company purchases green beans of coffee and produces coffees of different types by roasting. The Company's product portfolio consists of roasted coffees including whole beans, crushed beans, triangular tea bags, square tea bags and hand drips, instant coffees including coffee mixes and instant bean coffees and coffee beverages including portion coffees and ice coffees. The Company also manufactures ethical (ETC) drugs including painkillers, diabetes diagnosis drugs and colonic irrigation drugs and over the counter (OTC) drugs including cold medicines, hair restorers and cold medicines for children.
Sector
Food Processing
Calendar
12/05/2024
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +8.98% | 37.34M | |
| +0.69% | 12.5B | |
| +24.50% | 1.57B | |
| +1.87% | 991M | |
| +3.04% | 930M | |
| -.--% | 729M | |
| -8.00% | 640M | |
| +6.21% | 565M | |
| -2.83% | 284M | |
| +1.93% | 255M |
- Stock Market
- Equities
- A222980 Stock
